TScan Therapeutics, Inc. (TCRX) released Loss for second quarter in line with the Street estimates.
The company's earnings came in at -$31.66 million, or -$0.28 per share. This compares with -$24.05 million, or -$0.51 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.28 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 82.9% to $0.54 million from $3.15 million last year.
TScan Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$31.66 Mln. vs. -$24.05 Mln. last year.
-EPS (Q2): -$0.28 vs. -$0.51 last year.
-Revenue (Q2): $0.54 Mln vs. $3.15 Mln last year.
For comments and feedback: editorial@rttnews.com